Cited 23 time in
Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Amatya, Reeju | - |
| dc.contributor.author | Kim, Doyeon | - |
| dc.contributor.author | Min, Kyoung Ah | - |
| dc.contributor.author | Shin, Meong Cheol | - |
| dc.date.accessioned | 2022-12-26T05:40:36Z | - |
| dc.date.available | 2022-12-26T05:40:36Z | - |
| dc.date.issued | 2022-11 | - |
| dc.identifier.issn | 2093-5552 | - |
| dc.identifier.issn | 2093-6214 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/804 | - |
| dc.description.abstract | Purpose A hydrogel containing dextran-coated iron oxide nanoparticles (DEX-IONP) was developed, and its applicability in topical photothermal therapy (PTT) of skin cancer was explored in vitro and in vivo. Methods DEX-IONP carbopol hydrogel was prepared by adopting the pH-triggered in situ gel-forming method. After preparation, physical characteristics and the photothermal activities of the DEX-IONP gel were evaluated in vitro in varying DEX-IONP concentrations. The photothermal activity was further examined in B16F10 s.c. tumor-bearing mice. Lastly, the efficacy of DEX-IONP gel-based topical PTT was evaluated in vivo. Results The prepared DEX-IONP gel retained high viscosity favorable to maintain at the applied site. In addition, the DEX-IONP gel could induce effective heating by laser irradiation. The cellular and in vivo studies evidenced the applicability of DEX-IONP in topical PTT. Finally, the preliminary efficacy study results in the B16F10 s.c. mice model demonstrated that tumor volumes could be significantly reduced by the topical PTT with DEX-IONP gel. Notably, by a single PTT treatment with 100 mu gFe/mL DEX-IONP gel and applying 0.5 W laser power for 10 min, the tumor growth could be significantly inhibited by 85%. Conclusion Overall, our results demonstrate that DEX-IONP gels may serve as an effective topical PTT agent. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 한국약제학회 | - |
| dc.title | Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer | - |
| dc.title.alternative | Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/s40005-022-00593-9 | - |
| dc.identifier.scopusid | 2-s2.0-85135224981 | - |
| dc.identifier.wosid | 000834702000002 | - |
| dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.52, no.6, pp 775 - 785 | - |
| dc.citation.title | Journal of Pharmaceutical Investigation | - |
| dc.citation.volume | 52 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 775 | - |
| dc.citation.endPage | 785 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002896835 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordPlus | GENE | - |
| dc.subject.keywordPlus | GEL | - |
| dc.subject.keywordAuthor | Iron oxide nanoparticles | - |
| dc.subject.keywordAuthor | Hydrogel | - |
| dc.subject.keywordAuthor | Photothermal therapy | - |
| dc.subject.keywordAuthor | Cancer | - |
| dc.subject.keywordAuthor | Topical application | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
